Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893089685> ?p ?o ?g. }
- W2893089685 endingPage "293" @default.
- W2893089685 startingPage "285" @default.
- W2893089685 abstract "Cannabinoids may be useful in the treatment of CNS disorders including drug abuse and addiction, where both CB1R antagonists / inverse agonists and CB2R agonists have shown preclinical efficacy. TV-5-249 and TV-6-41, two novel aminoalkylindoles with dual action as neutral CB1R antagonists and CB2R agonists, previously attenuated abuse-related effects of ethanol in mice. To further characterize these drugs, TV-5-249 and TV-6-41 were compared with the CB1R antagonist / inverse agonist rimonabant in assays relevant to adverse effects and cannabinoid withdrawal. The cannabinoid tetrad confirmed that TV-5-249 and TV-6-41 were devoid of CB1R agonist effects at behaviorally-relevant doses, and neither of the novel drugs induced rimonabant-like scratching. Generalized aversive effects were assessed, and rimonabant and TV-5-249 induced taste aversion, but TV-6-41 did not. Schedule-controlled responding and observation of somatic signs were used to assess withdrawal-like effects precipitated by rimonabant or TV-6-41 in mice previously treated with the high-efficacy CB1R agonist JWH-018 or vehicle. Rimonabant and TV-6-41 dose-dependently suppressed response rates in all subjects, but TV-6-41 did so more potently in JWH-018-treated mice than in vehicle-treated mice, while rimonabant equally suppressed responding in both groups. Importantly, rimonabant elicited dramatic withdrawal signs, but TV-6-41 did not. These findings suggest differences in both direct adverse effects and withdrawal-related effects elicited by rimonabant, TV-5-249, and TV-6-41, which could relate to neutral CB1R antagonism, CB2R agonism, or a combination of both. Both mechanisms should be explored and exploited in future drug design efforts to develop pharmacotherapies for drug dependence." @default.
- W2893089685 created "2018-10-05" @default.
- W2893089685 creator A5029982811 @default.
- W2893089685 creator A5035496277 @default.
- W2893089685 creator A5045811374 @default.
- W2893089685 creator A5053774142 @default.
- W2893089685 creator A5054560856 @default.
- W2893089685 creator A5058779865 @default.
- W2893089685 creator A5069839288 @default.
- W2893089685 date "2018-11-01" @default.
- W2893089685 modified "2023-09-26" @default.
- W2893089685 title "Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice" @default.
- W2893089685 cites W1439137070 @default.
- W2893089685 cites W1495188205 @default.
- W2893089685 cites W1596640114 @default.
- W2893089685 cites W182927737 @default.
- W2893089685 cites W1921386713 @default.
- W2893089685 cites W1961696944 @default.
- W2893089685 cites W1968753875 @default.
- W2893089685 cites W1971698096 @default.
- W2893089685 cites W1975748753 @default.
- W2893089685 cites W1977997231 @default.
- W2893089685 cites W1982609407 @default.
- W2893089685 cites W1982900748 @default.
- W2893089685 cites W1983509349 @default.
- W2893089685 cites W1986056996 @default.
- W2893089685 cites W1988952674 @default.
- W2893089685 cites W1991186544 @default.
- W2893089685 cites W1991778481 @default.
- W2893089685 cites W1993764059 @default.
- W2893089685 cites W1999687457 @default.
- W2893089685 cites W2021765490 @default.
- W2893089685 cites W2026290368 @default.
- W2893089685 cites W2026710536 @default.
- W2893089685 cites W2029544993 @default.
- W2893089685 cites W2041841378 @default.
- W2893089685 cites W2063808330 @default.
- W2893089685 cites W2067312146 @default.
- W2893089685 cites W2069217011 @default.
- W2893089685 cites W2071991061 @default.
- W2893089685 cites W2077916547 @default.
- W2893089685 cites W2080266144 @default.
- W2893089685 cites W2083229818 @default.
- W2893089685 cites W2084000997 @default.
- W2893089685 cites W2085163003 @default.
- W2893089685 cites W2086735669 @default.
- W2893089685 cites W2089712656 @default.
- W2893089685 cites W2095139799 @default.
- W2893089685 cites W2104537532 @default.
- W2893089685 cites W2105220138 @default.
- W2893089685 cites W2113565543 @default.
- W2893089685 cites W2124650596 @default.
- W2893089685 cites W2124733378 @default.
- W2893089685 cites W2135184362 @default.
- W2893089685 cites W2135530906 @default.
- W2893089685 cites W2147814145 @default.
- W2893089685 cites W2155415459 @default.
- W2893089685 cites W2162397661 @default.
- W2893089685 cites W2165269657 @default.
- W2893089685 cites W2168128112 @default.
- W2893089685 cites W2168432575 @default.
- W2893089685 cites W2170064412 @default.
- W2893089685 cites W2171445381 @default.
- W2893089685 cites W2171488764 @default.
- W2893089685 cites W2184025074 @default.
- W2893089685 cites W2236997873 @default.
- W2893089685 cites W2337155940 @default.
- W2893089685 cites W2463419736 @default.
- W2893089685 cites W2471283772 @default.
- W2893089685 cites W2528358697 @default.
- W2893089685 cites W2552012810 @default.
- W2893089685 cites W2746672637 @default.
- W2893089685 doi "https://doi.org/10.1016/j.drugalcdep.2018.08.011" @default.
- W2893089685 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6475911" @default.
- W2893089685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30300803" @default.
- W2893089685 hasPublicationYear "2018" @default.
- W2893089685 type Work @default.
- W2893089685 sameAs 2893089685 @default.
- W2893089685 citedByCount "5" @default.
- W2893089685 countsByYear W28930896852020 @default.
- W2893089685 countsByYear W28930896852021 @default.
- W2893089685 countsByYear W28930896852022 @default.
- W2893089685 crossrefType "journal-article" @default.
- W2893089685 hasAuthorship W2893089685A5029982811 @default.
- W2893089685 hasAuthorship W2893089685A5035496277 @default.
- W2893089685 hasAuthorship W2893089685A5045811374 @default.
- W2893089685 hasAuthorship W2893089685A5053774142 @default.
- W2893089685 hasAuthorship W2893089685A5054560856 @default.
- W2893089685 hasAuthorship W2893089685A5058779865 @default.
- W2893089685 hasAuthorship W2893089685A5069839288 @default.
- W2893089685 hasBestOaLocation W28930896852 @default.
- W2893089685 hasConcept C118552586 @default.
- W2893089685 hasConcept C126322002 @default.
- W2893089685 hasConcept C148001335 @default.
- W2893089685 hasConcept C15744967 @default.
- W2893089685 hasConcept C170493617 @default.
- W2893089685 hasConcept C197934379 @default.
- W2893089685 hasConcept C2776433454 @default.